MedTrace Logo

Investigation of the Presbia Flexivue Microlens™

NCT02110472 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 412

Last updated 2016-09-28

No results posted yet for this study

Summary

The Presbia Flexivue Microlens is a corneal inlay.

Conditions

Interventions

DEVICE

Corneal inlay

Presbia Flexivue Microlens implantation in corneal pocket created in nondominant eyes of emmetropic presbyopes.

Sponsors & Collaborators

  • PresbiBio, LLC

    lead INDUSTRY

Principal Investigators

  • Robert K Maloney, MD, MA · Maloney Vision Institute

  • Mickey Gordon, MD · Gordon-Weiss-Schanzlin Vision Institute

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2018-12-31
Completion
2019-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02110472 on ClinicalTrials.gov